Answers by TheMediTary.Com - Last updated: 12-Jul-2023
Brand names of testosterone include Androderm, AndroGel, Fortesta, Testim, Depo-Testosterone, Testopel, Aveed, Natesto, Vogelxo, Xyosted, Jatenzo, Tlando, and Kyzatrex.
Testosterone is an androgen indicated for testosterone replacement therapy in males. It is used to treat male hypogonadism, a condition in which the body doesn't produce enough testosterone. Male hypogonadism may be congenital (present from birth), or acquired (from injury or infection).
Testosterone is a Schedule III controlled substance in the Controlled Substances Act. Testosterone should always be stored in a safe place to prevent misuse.
Testosterone is available in a number of dosage forms. Some branded products may also be available as a generic.
FDA Approved Testosterone Products
Brand | Dosage Form | Company | Approved |
Androderm (testosterone) | transdermal system (patch) | Allergan plc | September 29, 1995 |
AndroGel (testosterone) |
transdermal gel | AbbVie Inc. | February 28, 2000 |
Aveed (testosterone undecanoate) |
intramuscular injection | Endo Pharmaceuticals, Inc. | March 5, 2014 |
Depo-Testosterone (testosterone cypionate) | intramuscular injection | Pharmacia and Upjohn Company LLC | July 25, 1979 |
Fortesta (testosterone) |
transdermal gel | Endo Pharmaceuticals, Inc. | December 29, 2010 |
Jatenzo (testosterone undecanoate) |
capsules | Clarus Therapeutics, Inc. | March 27, 2019 |
Kyzatrex (testosterone undecanoate) |
capsules | Marius Pharmaceuticals | July 27, 2022 |
Natesto (testosterone) |
nasal gel | Aytu BioScience, Inc. | May 28, 2014 |
Testim (testosterone) |
transdermal gel | Endo Pharmaceuticals, Inc. | October 31, 2002 |
Testopel (testosterone) |
pellet (implant) | Endo Pharmaceuticals, Inc. | July 13, 1972 |
Tlando (testosterone) |
capsules | Antares Pharma, Inc. | March 28, 2022 |
Vogelxo (testosterone) |
transdermal gel | Upsher-Smith Laboratories, LLC | June 4, 2014 |
Xyosted (testosterone enanthate) |
subcutaneous injection (autoinjector) | Antares Pharma, Inc. | September 28, 2018 |